<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7">
 <label>7.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Feagan</surname>
    <given-names>BG</given-names>
   </name>
   <name>
    <surname>Sandborn</surname>
    <given-names>WJ</given-names>
   </name>
   <name>
    <surname>Gasink</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Jacobstein</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Lang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Friedman</surname>
    <given-names>JR</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Ustekinumab as induction and maintenance therapy for Crohn's Disease</article-title>. 
  <source>N Engl J Med.</source> (
  <year>2016</year>) 
  <volume>375</volume>:
  <fpage>1946</fpage>â€“
  <lpage>60</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1602773</pub-id>
  <?supplied-pmid 27959607?>
  <pub-id pub-id-type="pmid">27959607</pub-id>
 </mixed-citation>
</ref>
